Merck Legal News Articles & Interviews

Hartford, CT A lawsuit has been filed against Merck alleging the company violated Employee Retirement Income Security Act (ERISA) laws in its managing of employee investments in Merck Plans. The lawsuit was filed June 20, 2008, in New Jersey.

Whitehouse Station, NJ Merck's role in the alleged delay of the ENHANCE study that ultimately revealed the truth about Vytorin, may have served to mislead more than the drug-buying public. The two-year wait for the truth about the anti-cholesterol drug may have also served to pull the wool over the eyes of those Merck employees, and investors in various Merck employee savings plans and 401(k) plans incurring huge losses.

Whitehouse Station, NJ When Merck dragged its feet for 21 months before releasing the ENHANCE study shaming Vytorin, the manufacturer allegedly did more than delay the bad news: it may have also delayed the returns, and derailed the retirement plans of thousands of investors unaware of a ticking time bomb. But Merck knew, and in so doing may have breached its fiduciary duty to investors under ERISA guidelines.